A laboratory of an Italian university hospital developed selective chip-panels to detect COVID-19 susceptibility/resistance alleles. Panels are validated in terms of sensitivity, precision and specificity identifying at risk alleles according to clinical phenotypes. Industries or universities are sought for a technical cooperation to extend the product. Pharmaceutical companies or investors are sought for financial or license agreement to further develop the product in diagnostics.
Solicite mayor información mencionando el código de referencia.